There have been 11 further Coronavirus-related deaths and 390 new cases, according to figures released by the health authorities today.
Of the deaths notified today, 4 occurred in April, 2 in March, 4 in February and 1 in January.
The median age of those who died was 83 years and the age range was 50-93 years.
With less than seven new cases announced today, Laois now has a 14-day incidence rate of 124.
Of the cases notified today:
- 215 are men / 174 are women
- 67% are under 45 years of age
- The median age is 34 years old
- 172 in Dublin, 42 in Kildare, 21 in Meath, 20 in Tipperary, 18 in Donegal and the remaining 117 cases are spread across 19 other counties.
As of 8am today, 179 COVID-19 patients are hospitalised, of which 48 are in ICU. 18 additional hospitalisations in the past 24 hours.
As of April 18th, 2021, 1,208,459 doses of COVID-19 vaccine have been administered in Ireland:
- 855,512 people have received their first dose
- 352,947 people have received their second dose
The COVID-19 Dashboard provides up-to-date information on the key indicators of COVID-19 in the community including daily data on Ireland’s COVID-19 Vaccination Programme.
New Cases in Laois
- April 19 – 7
- April 18 – 2
- April 17 – Not Provided
- April 16 – 10
- April 15 – 11
- April 14 – 8
- April 13 – 9
- April 12 – 6
- April 11 – 12
- April 10 – 2
- April 9 – 15
- April 8 – 7
- April 7 – 13
- April 6 – 6
- April 5 – 12
14-day case rate in Laois per 100,000 population
- April 19 – 124
- April 18 – 129.9
- April 16/17 – Not Provided
- April 15 – 160.6
- April 14 – 178.3
- April 13 – 188.9
- April 12 – 196
- April 11 – 201.9
- April 9/10 – Not Provided
- April 8 – 231.4
- April 7 – 240.6
- April 6 – 232.6
New cases in Laois during past 14 days
- April 19 – 105
- April 18 – 110
- April 17 – Not Provided
- April 16 – 146
- April 15 – 136
- April 14 – 151
- April 13 – 160
- April 12 – 166
- April 11 – 171
- April 10 – 195
- April 9 – 211
- April 8 – 196
- April 7 – 204
- April 6 – 197
Johnson & Johnson Covid-19 vaccine declared safe
The European Medicines Agency has said the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks.
Use of the company’s one-dose vaccine was temporarily halted by US regulators last week after a small number of blood clots were reported.
Europe’s drug regulator said it had found a possible link between Johnson & Johnson’s Covid-19 vaccine and rare blood clotting issues in adults who had received the shot in the United States.
The EMA said its safety committee concluded that a warning about unusual blood clots with low blood platelets should be added to the vaccine’s labels.
The news from the European Medicines Agency that the overall benefit versus risk with the J&J jab remains positive will be welcomed by health officials in Ireland.
Ireland is due around 600,000 doses of the single dose vaccine between now and June.
Over 40,000 had been due tomorrow and the Health Service Executive will be looking to establish how soon the first batch will now come.
